Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1976 Sep;10(3):571–572. doi: 10.1128/aac.10.3.571

Antiviral Effects of Virazole in Chronic Hepatitis B Surface Antigen-Seropositive Chimpanzees

Alexander E Denes 1, James W Ebert 1, Kenneth R Berquist 1, Bert L Murphy 1, James E Maynard 1
PMCID: PMC429791  PMID: 984798

Abstract

Virazole (Ribavirin, ICN 1229), a broad-spectrum, antiviral chemotherapeutic agent was used to treat two adult chronically hepatitis B surface antigen (HBs Ag)-seropositive chimpanzees. No significant change in serum hepatitis B surface antigen was noted and no adverse reactions were observed. The role of viral replication in the chronic carrier state of hepatitis B is discussed.

Full text

PDF
571

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almeida J. D., Rubenstein D., Stott E. J. New antigen-antibody system in Australia-antigen-positive hepatitis. Lancet. 1971 Dec 4;2(7736):1225–1227. doi: 10.1016/s0140-6736(71)90543-5. [DOI] [PubMed] [Google Scholar]
  2. Barker L. F., Chisari F. V., McGrath P. P., Dalgard D. W., Kirschstein R. L., Almeida J. D., Edington T. S., Sharp D. G., Peterson M. R. Transmission of type B viral hepatitis to chimpanzees. J Infect Dis. 1973 Jun;127(6):648–662. doi: 10.1093/infdis/127.6.648. [DOI] [PubMed] [Google Scholar]
  3. Berquist K. R., Peterson J. M., Murphy B. L., Ebert J. W., Maynard J. E., Purcell R. H. Hepatitis B antigens in serum and liver of chimpanzees acutely infected with hepatitis B virus. Infect Immun. 1975 Sep;12(3):602–605. doi: 10.1128/iai.12.3.602-605.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brzosko W. J., Madaliński K., Krawczyński K., Nowoslawski A. Duality of hepatitis B antigen and its antibody. I. Immunofluorescence studies. J Infect Dis. 1973 Apr;127(4):424–428. doi: 10.1093/infdis/127.4.424. [DOI] [PubMed] [Google Scholar]
  5. Huang S. N., Millman I., O'Connell A., Aronoff A., Gault H., Blumberg B. S. Virus-like particles in Australia antigen-associated hepatitis. An immunoelectron microscopic study of human liver. Am J Pathol. 1972 Jun;67(3):453–470. [PMC free article] [PubMed] [Google Scholar]
  6. Ling C. M., Overby L. R. Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody. J Immunol. 1972 Oct;109(4):834–841. [PubMed] [Google Scholar]
  7. Sidwell R. W., Huffman J. H., Khare G. P., Allen L. B., Witkowski J. T., Robins R. K. Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science. 1972 Aug 25;177(4050):705–706. doi: 10.1126/science.177.4050.705. [DOI] [PubMed] [Google Scholar]
  8. Streeter D. G., Witkowski J. T., Khare G. P., Sidwell R. W., Bauer R. J., Robins R. K., Simon L. N. Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. Proc Natl Acad Sci U S A. 1973 Apr;70(4):1174–1178. doi: 10.1073/pnas.70.4.1174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Zuñiga C. B., de Almeida C., Iervolino A. C., Castro I. de O., Galvão P. A. Aço do 1-beta-D-ribofuranosyl, 1,2,4-triazol-3-carboxamida no tratamento das hepatites virais agudas. AMB Rev Assoc Med Bras. 1974 Nov;20(11):386–390. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES